These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1302 related items for PubMed ID: 29587665

  • 1. Neoadjuvant chemotherapy followed by concurrent chemoradiotherapy versus concurrent chemoradiotherapy followed by adjuvant chemotherapy in locally advanced nasopharyngeal carcinoma.
    Setakornnukul J, Thephamongkhol K.
    BMC Cancer; 2018 Mar 27; 18(1):329. PubMed ID: 29587665
    [Abstract] [Full Text] [Related]

  • 2. Neoadjuvant chemotherapy plus intensity-modulated radiotherapy versus concurrent chemoradiotherapy plus adjuvant chemotherapy for the treatment of locoregionally advanced nasopharyngeal carcinoma: a retrospective controlled study.
    Qiu WZ, Huang PY, Shi JL, Xia HQ, Zhao C, Cao KJ.
    Chin J Cancer; 2016 Jan 06; 35():2. PubMed ID: 26739148
    [Abstract] [Full Text] [Related]

  • 3. Comparison of concurrent chemoradiotherapy versus neoadjuvant chemotherapy followed by radiation in patients with advanced nasopharyngeal carcinoma in endemic area: experience of 128 consecutive cases with 5 year follow-up.
    Wu SY, Wu YH, Yang MW, Hsueh WT, Hsiao JR, Tsai ST, Chang KY, Chang JS, Yen CJ.
    BMC Cancer; 2014 Oct 28; 14():787. PubMed ID: 25351202
    [Abstract] [Full Text] [Related]

  • 4. Neoadjuvant chemotherapy followed by concurrent chemoradiotherapy versus concurrent chemoradiotherapy alone in locoregionally advanced nasopharyngeal carcinoma: A phase III multicentre randomised controlled trial.
    Cao SM, Yang Q, Guo L, Mai HQ, Mo HY, Cao KJ, Qian CN, Zhao C, Xiang YQ, Zhang XP, Lin ZX, Li WX, Liu Q, Qiu F, Sun R, Chen QY, Huang PY, Luo DH, Hua YJ, Wu YS, Lv X, Wang L, Xia WX, Tang LQ, Ye YF, Chen MY, Guo X, Hong MH.
    Eur J Cancer; 2017 Apr 28; 75():14-23. PubMed ID: 28214653
    [Abstract] [Full Text] [Related]

  • 5. Survival benefit of induction chemotherapy for locally advanced nasopharyngeal carcinoma: prognosis based on a new risk estimation model.
    Liu W, Yu B, Luo Y, Li J, Yuan X, Wu S, Liang B, Lv Z, Li Y, Peng X, Lu J, Peng X, Liu X.
    BMC Cancer; 2021 May 29; 21(1):639. PubMed ID: 34051750
    [Abstract] [Full Text] [Related]

  • 6. The effect of adjuvant chemotherapy on survival in patients with residual nasopharyngeal carcinoma after undergoing concurrent chemoradiotherapy.
    Yang S, Lin S, Fu Q, Cai B, Kong F, Huang G, Li F, Wang H.
    PLoS One; 2015 May 29; 10(3):e0120019. PubMed ID: 25799566
    [Abstract] [Full Text] [Related]

  • 7. Neoadjuvant chemotherapy plus intensity-modulated radiotherapy versus neoadjuvant chemotherapy plus concurrent chemoradiotherapy for ascending or descending types of nasopharyngeal carcinoma: A retrospective study.
    Lin Q, Lu L, Wang X, Lin Y, Chen Y, Chen H, Chen S, Lin S, Zhang Y, Zheng P, Chen X.
    Am J Otolaryngol; 2022 May 29; 43(1):103193. PubMed ID: 34509080
    [Abstract] [Full Text] [Related]

  • 8. Comparison of concurrent chemoradiotherapy versus induction chemotherapy followed by radiation in patients with nasopharyngeal carcinoma.
    Komatsu M, Tsukuda M, Matsuda H, Horiuchi C, Taguch T, Takahashi M, Nishimura G, Mori M, Niho T, Ishitoya J, Sakuma Y, Hirama M, Shiono O.
    Anticancer Res; 2012 Feb 29; 32(2):681-6. PubMed ID: 22287763
    [Abstract] [Full Text] [Related]

  • 9. Final results of a randomized phase III trial of induction chemotherapy followed by concurrent chemoradiotherapy versus concurrent chemoradiotherapy alone in patients with stage IVA and IVB nasopharyngeal carcinoma-Taiwan Cooperative Oncology Group (TCOG) 1303 Study.
    Hong RL, Hsiao CF, Ting LL, Ko JY, Wang CW, Chang JTC, Lou PJ, Wang HM, Tsai MH, Lai SC, Liu TW.
    Ann Oncol; 2018 Sep 01; 29(9):1972-1979. PubMed ID: 30016391
    [Abstract] [Full Text] [Related]

  • 10. Induction chemotherapy followed by concurrent chemoradiotherapy versus concurrent chemoradiotherapy alone in locoregionally advanced nasopharyngeal carcinoma: long-term results of a phase III multicentre randomised controlled trial.
    Yang Q, Cao SM, Guo L, Hua YJ, Huang PY, Zhang XL, Lin M, You R, Zou X, Liu YP, Xie YL, Wang ZQ, Mai HQ, Chen QY, Tang LQ, Mo HY, Cao KJ, Qian CN, Zhao C, Xiang YQ, Zhang XP, Lin ZX, Li WX, Liu Q, Li JB, Ling L, Guo X, Hong MH, Chen MY.
    Eur J Cancer; 2019 Sep 01; 119():87-96. PubMed ID: 31425966
    [Abstract] [Full Text] [Related]

  • 11. Induction chemotherapy plus IMRT alone versus induction chemotherapy plus IMRT-based concurrent chemoradiotherapy in locoregionally advanced nasopharyngeal carcinoma: a retrospective cohort study.
    Wei Z, Zhang Z, Luo J, Li N, Peng X.
    J Cancer Res Clin Oncol; 2019 Jul 01; 145(7):1857-1864. PubMed ID: 31062162
    [Abstract] [Full Text] [Related]

  • 12. IMRT combined with concurrent chemotherapy plus adjuvant chemotherapy versus IMRT combined with concurrent chemotherapy alone in patients with nasopharyngeal carcinoma.
    Zhong Q, Zhu X, Li L, Qu S, Liang Z, Zeng F, Pan X.
    Oncotarget; 2017 Jun 13; 8(24):39683-39694. PubMed ID: 28147309
    [Abstract] [Full Text] [Related]

  • 13. The efficacy of induction chemotherapy in the treatment of stage II nasopharyngeal carcinoma in intensity modulated radiotherapy era.
    Li PJ, Mo HY, Luo DH, Hu WH, Jin T.
    Oral Oncol; 2018 Oct 13; 85():95-100. PubMed ID: 30220326
    [Abstract] [Full Text] [Related]

  • 14. Comparison of the efficacy between concurrent chemoradiotherapy with or without adjuvant chemotherapy for stage II nasopharyngeal carcinoma.
    Chen J, Liu T, Sun Q, Jin T.
    Medicine (Baltimore); 2020 Jul 17; 99(29):e20443. PubMed ID: 32702809
    [Abstract] [Full Text] [Related]

  • 15. Neoadjuvant chemotherapy followed by concurrent chemoradiation for locally advanced nasopharyngeal carcinoma.
    Kong L, Zhang YW, Hu CS, Guo Y.
    Chin J Cancer; 2010 May 17; 29(5):551-5. PubMed ID: 20426907
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. MRI-based radiomics to compare the survival benefit of induction chemotherapy plus concurrent chemoradiotherapy versus concurrent chemoradiotherapy plus adjuvant chemotherapy in locoregionally advanced nasopharyngeal carcinoma: A multicenter study.
    Shen H, Yin J, Niu R, Lian Y, Huang Y, Tu C, Liu D, Wang X, Lan X, Yuan X, Zhang J.
    Radiother Oncol; 2022 Jun 17; 171():107-113. PubMed ID: 35461950
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 66.